library.onepin.app/semax-selank-blend Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Cognitive & Mood Pre-mixed nootropic blendNot FDA-approved · research compound

Semax / Selank Blend

Semax + Selank Stack

5-10 units SubQ or 100-200mcg each intranasal – 300-600 mcg total SubQ Daily, morning preferred (Semax is stimulating)
Semax + Selank combinationBDNF upregulator + anxiolytic pairCalm focus nootropic stackApproved dual-peptide combination (Russia)

The Semax / Selank Blend is the classic nootropic duo combining stimulating cognitive enhancement with calming anxiolytic support in a single vial. Semax upregulates BDNF and TrkB signaling for neuroplasticity and focus, while Selank modulates GABA and serotonin for anxiety reduction without sedation. The combination provides balanced nootropic effects: mental sharpness and drive from Semax tempered by the calm emotional regulation of Selank, creating a focused but relaxed cognitive state often described as calm alertness.

Quick Start
Route
Subcutaneous (SubQ) injection or intranasal
Start low
5-10 units SubQ
Frequency
Daily, morning preferred (Semax is stimulating)
Timing
No fasting required

Starting dose. 5-10 units — SubQ or 100-200mcg each intranasal

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
BLEND TOTAL — The displayed dose is a combined vial total, not a per-component dose. This record does not establish the component ratio; verify the exact compounding label.
5-10 units SubQ or 100-200mcg each intranasal · Subcutaneous (SubQ) injection or intranasal · Daily, morning preferred (Semax is stimulating)
conservative starter
5-10 units SubQ or 100-200mcg each intranasal
Daily, morning preferred (Semax is stimulating)
Intermediate
Balanced Focus
BLEND TOTAL — The displayed dose is a combined vial total, not a per-component dose. This record does not establish the component ratio; verify the exact compounding label.
300-600 mcg total · SubQ · Daily
anecdotal · community
The classic 'God Mode' nootropic stack. Semax provides the BDNF and dopamine push; Selank smooths the edges and prevents anxiety.
300-600 mcg total
Daily
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

The Semax / Selank Blend provides balanced nootropic effects through two complementary neuromodulatory mechanisms:

Semax Component: Activates melanocortin receptors (MC3R, MC4R) in the brain, triggering BDNF expression and TrkB receptor activation in the hippocampus and cortex. BDNF is the primary neurotrophin supporting neuronal survival, synaptic plasticity, and the cellular basis of learning and memory. Semax also modulates serotonergic and dopaminergic neurotransmission, increases NGF and GDNF expression, and enhances cerebral blood flow. The Pro-Gly-Pro extension protects against DPP-IV and aminopeptidase degradation. Semax does NOT stimulate adrenal cortisol production at standard doses.

Selank Component: Modulates GABA-A receptor sensitivity to enhance inhibitory neurotransmission without directly binding the benzodiazepine site, preventing sedation and dependence. Influences serotonin (5-HT) metabolism through tryptophan hydroxylase and serotonin transporter dynamics. The tuftsin core (Thr-Lys-Pro-Arg) provides immunomodulatory activity including enhanced phagocyte function, NK cell activity, and IL-6 expression. Gene expression studies show Selank modulates approximately 80 genes related to GABAergic, serotonergic, and immune pathways.

Synergy: Semax provides the stimulating cognitive edge (BDNF, dopamine, cerebral blood flow) while Selank provides the calming anxiolytic foundation (GABA, serotonin). This prevents the jitteriness or overstimulation that can accompany cognitive enhancers used alone. The result is a balanced state of calm alertness optimal for sustained mental work, creative tasks, and high-pressure cognitive demands.

02

What to expect

Early
Days 1–7

Days 1-7: Semax cognitive effects often noticeable from the first dose - improved focus, verbal fluency, mental stamina, and motivation. Selank anxiolytic calming typically felt within 1-2 doses, with reduced background anxiety and improved emotional stability. The combination produces a distinctive calm-yet-sharp mental state. Mild injection site effects possible.

Mid
Weeks 2–4

Weeks 2-4: Cumulative BDNF upregulation from Semax produces sustained cognitive enhancement beyond the acute dose window. Selank GABA/serotonin modulation becomes more consistent and stable. Memory formation and recall noticeably improved. Stress resilience increases. Many users report this as the period where the combination's benefits become most apparent in daily performance.

Later
Weeks 4–12

Weeks 4-12: Full neuroplasticity benefits from sustained BDNF elevation. Long-term memory and learning capacity at peak. Selank gene expression changes (approximately 80 genes) fully expressed. Immune function may show improvement. Consider cycling off after 8-12 weeks with a 4-week break to maintain receptor sensitivity and prevent tolerance to the cognitive effects.

03

Evidence

HumanStrong
AnimalStrong
In-vitroPresent

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 5-10 units SubQ or 100-200mcg each intranasal via Subcutaneous (SubQ) injection or intranasal, Daily, morning preferred (Semax is stimulating). No checked live PubMed abstract supported this complete molecule/formulation/route/dose/frequency combination.

Mechanism: The Semax / Selank Blend provides balanced nootropic effects through two complementary neuromodulatory mechanisms: Semax Component: Activates melanocortin receptors (MC3R, MC4R) in the brain, triggering BDNF expression a. No checked live abstract supported this full mechanistic claim at the card's formulation/route without extrapolation.

Primary safety claim: Mild stimulation from Semax component (avoid late-day dosing). No checked live abstract directly established this as the primary concern for the card's exact formulation and regimen.

04

The honest take

Both components are approved prescription medications with human clinical data

True. Semax and Selank hold regulatory approval in Russia as prescription medications. This represents the strongest regulatory validation of any nootropic peptide blend, though Western regulatory agencies have not independently evaluated them.

Produces calm alertness - cognitive stimulation without anxiety or jitteriness
Supported

Mechanistically well-supported. Semax stimulates via BDNF/dopamine/cerebral blood flow while Selank calms via GABA/serotonin modulation. The opposing but complementary mechanisms logically produce balanced cognitive enhancement. Russian clinical use supports this characterization, though the specific combined subjective profile has not been rigorously studied.

Semax upregulates BDNF for neuroplasticity and neuroprotection
Supported

Well-supported by animal and in vitro data. BDNF upregulation through melanocortin receptor activation and TrkB signaling is extensively characterized. Human neuroprotective benefits observed in stroke recovery trials. Direct BDNF measurement in human brain tissue is not feasible, so the human evidence is indirect.

05

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

GHK-CuSemax Met-1 and His-3 are susceptible to copper oxidation during prolonged co-storage, but seconds of syringe contact during draw-and-inject is negligible. Safe for draw-and-inject. Draw GHK-Cu LAST.
LL-37No anionic charge issues in either component. Neither Semax nor Selank is anionic. Safe in same syringe.
IpamorelinGH secretagogue. No residue conflicts. Safe in same syringe.
CJC-1295 no DAC / Ipamorelin BlendGH axis stimulation. No residue conflicts. Safe in same syringe.

Keep separate

CJC-1295 with DACDAC maleimide linker may react with peptides in syringe. Pin CJC-DAC separately.
NAD+Acidic pH can denature peptide components. Pin separately.
GlutathioneThiol chemistry may interfere with peptide stability. Pin separately.
OxytocinOxytocin contains cysteine residues. Pin separately to avoid potential interactions.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

06

Side effects & safety

Commonly reported

  • Mild stimulation from Semax component (avoid late-day dosing)
  • Occasional lightheadedness immediately post-injection
  • Mild injection site redness or warmth
  • Nasal congestion if using intranasal route

Less common & notes

  • Rarely reported: headache, transient nausea, mild restlessness from Semax in sensitive individuals, brief drowsiness from Selank (paradoxical in some users).
  • Both Semax and Selank are approved prescription medications in Russia with established safety profiles and published human pharmacokinetic data.
  • Long-term safety data for this specific combination beyond Russian clinical experience is limited.
07

Pharmacokinetics

Illustrative plasma concentration · 17 h
Half-life

Semax: ~30 min; Selank: ~30 min

Peak · Tmax

Semax: ~20 min; Selank: ~45 min

Elimination

Semax: ~2.5 hours; Selank: ~2.5 hours

Bioavailability

Both ~100% SubQ; Semax ~60% nasal; Selank ~92% nasal

Duration of action

Semax: 6-12 hours (BDNF upregulation and cognitive effects cumulative with daily dosing); Selank: 6-12 hours (anxiolytic and GABA/serotonin modulation effects outlast plasma presence)

Clearance

Enzymatic degradation by aminopeptidases. Pro-Gly-Pro C-terminal extension on both peptides slows degradation compared to native ACTH(4-10) and tuftsin.

Storage. Reconstitute with bacteriostatic water. Store refrigerated at 2-8 degrees C. Shelf life approximately 28 days after reconstitution. Semax contains Met-1 which can oxidize over time; avoid prolonged light exposure and maintain cold storage. Do not freeze after reconstitution. Discard if cloudy or particulate matter visible.

08

Regulatory status

Not FDA-approved. Both Semax and Selank are approved prescription medications in Russia and Ukraine for cognitive enhancement, neuroprotection (Semax), and anxiety (Selank). Outside Russia, classified as research peptides. Available through compounding pharmacies and research suppliers. All use of this blend outside Russia/Ukraine is experimental and off-label.

Put it to work

Calculate, log & track

Open Semax / Selank Blend straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Semax / Selank Blend in the app →

Go deeper

The guide & community

The complete Semax / Selank Blend walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.